Clinical trials
Antineutrophil Cytoplasmic Antibody-associated Vasculitis clinical trials
Below are recruiting antineutrophil cytoplasmic antibody-associated vasculitis clinical trials, each written for real people, not researchers. We’re tracking 3 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06733935RecruitingPhase 1/Phase 2
Study of NKX019 for immune diseases
This trial tests an investigational cell therapy called NKX019 for people with certain autoimmune diseases like scleroderma, myositis, vasculitis, or rheumatoid arthritis. It aims to see if NKX019 can help control the disease when standard treatments have not worked well enough.
Orange, CaliforniaAges 18–75 - NCT06072482RecruitingPhase 4
Avacopan for ANCA vasculitis (GPA or MPA)
This study tests an oral medication called avacopan for people with active ANCA-associated vasculitis (GPA or MPA). It’s for those who need strong treatment to control their disease and aims to see if avacopan works as well as standard therapies.
Anchorage, AlaskaAges 18–100 - NCT07388277RecruitingPhase 1/Phase 2
CAR T-cell therapy for ANCA vasculitis
This trial tests a new CAR T-cell therapy (CC-97540) for people with active ANCA vasculitis (GPA or MPA) that has not responded to or has returned after standard treatments. The goal is to see if this personalized cell therapy can calm the immune system and reduce disease activity.
Boston, MassachusettsAges 18 years+
Hear when a new Antineutrophil Cytoplasmic Antibody-associated Vasculitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for antineutrophil cytoplasmic antibody-associated vasculitis?
- Yes. Clin2 currently lists 3 recruiting antineutrophil cytoplasmic antibody-associated vasculitis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a antineutrophil cytoplasmic antibody-associated vasculitis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a antineutrophil cytoplasmic antibody-associated vasculitis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
- ANCA Associated Vasculitis (AAV)
- ANCA Associated Systemic Vasculitis
- Metabolic Dysfunction-Associated Steatotic Liver Disease
- Ventilator Associated Pneumonia
- MASH - Metabolic Dysfunction-Associated Steatohepatitis
- Vasculitis
- Thyroid Associated Ophthalmopathy
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.